Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.

导出原文传递

翻译打印收藏纠错

第一作者： Steffen,Wolfsgruber

第一单位： Department of Psychiatry and Psychotherapy, University of Bonn, Germany.;German Center for Neurodegenerative Diseases, Bonn, Germany.

作者： Steffen,Wolfsgruber ^[1] ; Alexandra,Polcher ^[1] ; Alexander,Koppara ^[1] ; Luca,Kleineidam ^[1] ; Lutz,Frölich ^[2] ; Oliver,Peters ^[3] ; Michael,Hüll ^[4] ; Eckart,Rüther ^[5] ; Jens,Wiltfang ^[5] ; Wolfgang,Maier ^[1] ; Johannes,Kornhuber ^[6] ; Piotr,Lewczuk ^[7] ; Frank,Jessen ^[8] ; Michael,Wagner ^[1]

作者单位： Department of Psychiatry and Psychotherapy, University of Bonn, Germany.;German Center for Neurodegenerative Diseases, Bonn, Germany. ^[1] Department of Gerontopsychiatry, Central Institute of Mental Health, Mannheim, Germany. ^[2] Department of Psychiatry, Charité Berlin, Campus Benjamin Franklin, Berlin, Germany. ^[3] Center for Geriatric Medicine and Gerontology, University of Freiburg, Germany. ^[4] Department ofPsychiatry and Psychotherapy, University of Göttingen, Germany. ^[5] Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany. ^[6] Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.;Department of Neurodegeneration Diagnostics, Medical University of Biasłystok, and Departmentof Biochemical Diagnostics, University Hospital of Bialystok, Bialystok, Poland. ^[7] German Center for Neurodegenerative Diseases, Bonn, Germany.;Department of Psychiatry, University of Cologne, Germany. ^[8]

关键词 Alzheimer’s disease cerebrospinal fluid mild cognitive impairment subjective cognitive decline